In This Article, You'll Discover Understanding how NerveFreedom's unique formulation addresses multiple aspects of ner ...

CHELMSFORD, MA, USA & NOVI, MI, USA & DÜSSELDORF, Germany & TOKYO, Japan I July 02, 2025 I Asahi Kasei Pharma has started trial drug ...

Shares of Artelo Biosciences, Inc. (ARTL) more than doubled on Monday after the company announced favorable results from its ...

Cancer survivors often experience persistent physical symptoms long after treatment ends. Expert advice highlights holistic ...

Researchers reviewed cancer pain management strategies, including traditional Chinese medicine-based strategies such as acupoint therapies. Chinese researchers explored the role of traditional Chinese ...

Type 2 diabetes is a long-term condition where the body can’t use insulin properly, causing blood sugar levels to stay too ...

The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the forecast period 2024-2032.

VYVGART® SC, first-and-only IgG Fc-antibody fragment which specifically targets the neonatal Fc receptor (FcRn), now approved for use in Europe for CIDPApproval based on ADHERE clinical trial, the ...

The opioid crisis has made it even more urgent to come up with novel approaches to treating suffering. Finally there’s ...

Dr. Lucas Brown, DAOM, LAc, spoke with Studio 512 about how his clinic, Rosedale Acupuncture & Wellness, can help with chronic pain conditions, including peripheral neuropathy. Dr. Brown s… ...

Polyneuropathy can cause pain, discomfort, and mobility difficulties. Learn more about the types, causes, and symptoms, as well as how to diagnose and treat the condition.